Evolution of the Average Target: PharmaCorp Rx Inc.

Evolution of the Average Target - PharmaCorp Rx Inc.

Evolution of the Target Price: PharmaCorp Rx Inc.

Evolution of the Target Price - PharmaCorp Rx Inc.

Changes in Analyst Recommendations: PharmaCorp Rx Inc.

7b0881a.xlD0Vh-yg0zHu40B3XvZ_-PPRpE4c0fET9myXwu5zHM.ixu4M3Hl-zaE8tlUsDXq0pefDddOPgu8IfTbMnLgphixaMwyctrGIa3I2A~fc4beb5daa8ef2ff2402a93cb1f45ccd

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+64.61%
+71.62%
+12.14%
+16.39%
+50.26%
+66.88%
+20.76%
+17.07%
+27.36%
+25.1%
Average +37.22%
Weighted average by Cap. +42.21%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4050CAD
Average target price
0.6667CAD
Spread / Average Target
+64.61%
High Price Target
0.7000CAD
Spread / Highest target
+72.84%
Low Price Target
0.6000CAD
Spread / Lowest Target
+48.15%

Analyst Consensus Detail

Analyst consensus - PharmaCorp Rx Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - PharmaCorp Rx Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PharmaCorp Rx Inc.
  1. Stock Market
  2. Stocks
  3. PCRX Stock
  4. Consensus PharmaCorp Rx Inc.